Delivery Order SPE2DR25D2206-SPE2DR26F9CL1
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,116.22 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100 count) on October 24, 2025, with an ultimate completion date of October 27, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and is classified as a child contract under the company's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical. The place of performance is...
- The Defense Logistics Agency has awarded a delivery order valued at $1,257.43 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets in quantities of 100. This competitively awarded, firm fixed-price delivery order, issued on October 20, 2025, with an ultimate completion date of October 21, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract contains no set-aside designation and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,149.57 to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg, with an ultimate completion date of November 18, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance, which is also the vendor's corporate headquarters location. AmerisourceBergen Drug Corp serves as a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,890.69 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitive award, issued under firm fixed pricing with no set-aside designation, represents a continuation of the company's pharmaceutical supply services to federal medical procurement needs. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count packaging) on August 13, 2025, with a ceiling value of $1,715.50 and an ultimate completion date of August 14, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters. The delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) under a firm fixed-price contract with a ceiling value of $1,274.62. The award, issued on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a non-competitive delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,473.06 to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg on October 29, 2025. This is a firm fixed-price contract with an ultimate completion date of October 30, 2025, and was awarded competitively with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,360.04 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) on September 5, 2025, with an ultimate completion date of September 8, 2025. This competitive award utilizes firm fixed pricing and carries no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters and a major distribution hub for...
- The Defense Logistics Agency awarded a delivery order valued at $3,894.81 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) on November 3, 2025, with completion scheduled for November 4, 2025. This competitively awarded, non-set-aside contract utilized firm fixed pricing and identifies AmerisourceBergen's Conshohocken, Pennsylvania facility as the place of performance. The award represents a child contract under AmerisourceBergen's broader...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,586.06 for 100 tablets of Ambien CR 6.25 mg, with an ultimate completion date of September 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9CL1Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,064.54 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count packages) on November 20, 2025, with an ultimate completion date of November 21, 2025. The contract utilizes firm fixed pricing under a non-competitive, non-set-aside delivery order structure. Performance will be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, leverages its comprehensive IDC vehicle to fulfill critical pharmaceutical supply needs across military and federal healthcare systems. The parent SPE2DX contract enables the company to deliver a broad range of brand-name and generic medications, vaccines, and medical supplies to support global military healthcare operations and federal agencies including the Defense Health Agency and U.S. Coast Guard. As a prime vendor under DLA's pharmaceutical supply chain, AmerisourceBergen maintains the capacity to meet federal medical procurement requirements through competitive contracting, positioning the company as a strategic supplier for the Department of Defense's healthcare logistics operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 11/20/25 |